Recent advances in the use of molecular analyses to inform the diagnosis and prognosis of patients with polycythaemia vera
R Stuckey, MT Gómez-Casares - International Journal of Molecular …, 2021 - mdpi.com
Genetic studies in the past decade have improved our understanding of the molecular basis
of the BCR-ABL1-negative myeloproliferative neoplasm (MPN) polycythaemia vera (PV) …
of the BCR-ABL1-negative myeloproliferative neoplasm (MPN) polycythaemia vera (PV) …
[HTML][HTML] CD markers polymorphisms as prognostic biomarkers in hematological malignancies
S Shahrabi, M Ghanavat, MM Behzad… - Oncology …, 2020 - ncbi.nlm.nih.gov
The clusters of differentiation (CD) are surface molecules used for immunophenotyping of
cells. The expression of CD markers is widely used to classify hematological malignancies …
cells. The expression of CD markers is widely used to classify hematological malignancies …
Expression of blood cells associated CD markers and cardiovascular diseases: clinical applications in prognosis
H Haybar, M Maleki Behzad, S Shahrabi… - Laboratory …, 2020 - academic.oup.com
Abstract Background Cardiovascular diseases (CVDs) are a major cause of mortality
worldwide. The results of various studies have shown that abnormality in the frequency and …
worldwide. The results of various studies have shown that abnormality in the frequency and …
Spatial mapping of hematopoietic clones in human bone marrow
AL Young, HC Davis, MJ Cox, TM Parsons… - Blood cancer …, 2024 - AACR
Clonal hematopoiesis (CH) is the expansion of somatically mutated cells in the
hematopoietic compartment of individuals without hematopoietic dysfunction. Large CH …
hematopoietic compartment of individuals without hematopoietic dysfunction. Large CH …
[PDF][PDF] Trombose essencial: uma revisão da literatura
MLL Pereira, ALR Furtado, FCR Pinto, AC Flor… - Revista Brasileira de …, 2020 - rbac.org.br
Trombose essencial é uma das doenças mieloproliferativas crônicas, rara e de etiologia
ainda desconhecida, mas que apresenta risco alto de eventos trombóticos e/ou …
ainda desconhecida, mas que apresenta risco alto de eventos trombóticos e/ou …
Особенности клинических проявлений у пациентов с Ph-негативными миелопролиферативными заболеваниями с различным спектром драйверных мутаций
ДВ Гоголева, ГВ Сычугов - Уральский медицинский журнал. 2019.№ …, 2019 - elib.usma.ru
Проведен анализ клинический проявлений Ph-негативных миелопролиферативных
заболеваний у 145 пациентов с разными драйверными мутациями. Пациенты …
заболеваний у 145 пациентов с разными драйверными мутациями. Пациенты …
[PDF][PDF] Identification of Key Regulators of Myeloproliferative Neoplasms Based on Relevant Network Analysis
Z Gu, W Mei, Z Wang, X Wang… - Revista Argentina …, 2020 - revistaclinicapsicologica.com
Myeloproliferative neoplasm is a common disease in the hematology department clinically
with high mortality. In this study, we focused on the key regulators of myeloproliferative …
with high mortality. In this study, we focused on the key regulators of myeloproliferative …
[PDF][PDF] PRIMARY MYELOFIBROSIS: CLINICAL PATTERNS, DIAGNOSIS AND TREATMENT
Primary myelofibrosis (PMF), also known as agnogenic myeloid metaplasia, represents a
CMN, which emerges due to a clonal myeloid proliferation induced bystem cell malignant …
CMN, which emerges due to a clonal myeloid proliferation induced bystem cell malignant …